With ubituximab, a high percentage of patients maintained no signs of disease activity.

Published Date: 01 Mar 2023

After receiving ublituximab treatment, the majority of patients with relapsing multiple sclerosis showed that they could achieve and maintain no evidence of disease activity.

Read Full News

Latest News

AHA Reframes Brain Health as a Lifelong Process

A new AHA scientific statement says sleep, mental health, pollution, and childhood adversity can shape cognitive aging and dementia risk, underscoring that brain health is built across a lifetime.

A Stepwise Approach Can Support Healthy Sleep in Children

Minimize the use of medications that counteract melatonin as well as stimulating activities that trigger cortisol, one researcher advised.

Roche Gets Second European Approval for Alzheimer's Test

Swiss drugmaker Roche has received the CE mark - a ⁠European regulatory clearance allowing sale in the region - for its second ⁠Elecsys blood test for Alzheimer's disease.

FDA Approves Ocrelizumab for Pediatric Relapsing MS

The FDA approval makes ocrelizumab a new treatment option for children aged 10 years and older with relapsing-remitting multiple sclerosis.

Multimodal Approach Can Manage Depression in Children

Psychotherapy is the intervention of first choice, and pharmacotherapy can be considered when psychotherapy alone is not effective, one psychiatrist says.

Decoding Spinal Muscular Atrophy (SMA): From Phenotypic Diversity to Early Diagnosis

Decoding Spinal Muscular Atrophy (SMA): From Phenotypic Diversity to Early Diagnosis

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Latest News

A new AHA scientific statement says sleep, mental health, pollution, and childhood adversity can shape cognitive aging and dementia risk, underscoring that brain health is built across a lifetime.

Minimize the use of medications that counteract melatonin as well as stimulating activities that trigger cortisol, one researcher advised.

Swiss drugmaker Roche has received the CE mark - a ⁠European regulatory clearance allowing sale in the region - for its second ⁠Elecsys blood test for Alzheimer's disease.

The FDA approval makes ocrelizumab a new treatment option for children aged 10 years and older with relapsing-remitting multiple sclerosis.

Psychotherapy is the intervention of first choice, and pharmacotherapy can be considered when psychotherapy alone is not effective, one psychiatrist says.

Decoding Spinal Muscular Atrophy (SMA): From Phenotypic Diversity to Early Diagnosis

News All Time

Severe Malaria in Kids Linked to Certain Cognitive, Academic Deficits Years Later

Impairment persisted after episodes of cerebral malaria or severe malarial anemia

Rat Lungworm Is Now in My State. Is It in Yours Too?

The global, brain-invading parasite continues to spread

Suppressing a Sneeze May Have Led to Cerebrospinal Fluid Leak

While normally harmless, holding in a sneeze may in rare cases cause serious problems

Novel Agent Reduces Seizures in Treatment-Resistant Epilepsy

Adjunctive azetukalner cut monthly focal onset seizure frequency by 53% in phase III study

First Clinical Trial in MOGAD Meets Primary Endpoint

Satralizumab cuts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease

Cemdisiran siRNA Therapy Demonstrates Efficacy in Myasthenia Gravis

Investigational treatment improves outcomes without complete complement blockade

Stiff Person Syndrome Patients Regain Mobility After Single-Dose Cell Therapy

CAR-T therapy shows promise in clinical trial

Cell Therapy Slows Upper Limb Decline in Duchenne Muscular Dystrophy

Investigational deramiocel is back under FDA review again

Real-World Registry Study Shows Alzheimer's Drug Safety Outcomes

No new signals for lecanemab emerged in ALZ-NET

CDC Study Reveals a Sleep-Deprived Nation

Women were more likely than men to have trouble falling and staying asleep

First-Time Seizures Linked to Higher Cancer Risk, Study Finds

Seizures may be a clue to non-neurologic cancer, not just brain tumors

Decoding Coffee-Dementia Links; Three Alzheimer's Trajectories; Mumps Encephalitis

News and commentary from the world of neurology and neuroscience

FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation

Oral NMDA receptor antagonist gets an expanded indication

Study Examines if Prenatal Exposure to Sedatives Is Linked to Psych Disorders

South Korean study found no increased risk for 12 disorders among exposed offspring

New CDC Messaging May Be Eroding Trust in Vaccines, Survey Finds

Shift to uncertainty-based statements appears to increase vaccine hesitancy, according to study

Is Pure Autonomic Failure a Warning Sign for Parkinson's? What a New Study Shows.

High conversion rates to Parkinson's, dementia with Lewy bodies, or multiple system atrophy

Recommended News For You

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.

Health researchers discuss Medicaid cancer screening trends, best practices

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

Providing essential cancer care to rural communities

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.

'Sleep ALL night' program helps children with leukemia sleep better during treatment

Recommended Articles For You

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer 

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late 

Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives 

Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

2.

Eight Doctors Killed in Brazil's Horrifying Plane Crash

3.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

4.

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

5.

When Healthcare Chatbots Fall Short of Human Connection

1.

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor

2.

Unveiling the Complexity of Multiple Myeloma Staging

3.

Unlocking the Mysteries of Synovial Sarcoma: A New Hope for Treatment

4.

The Mysterious World of Petechiae: Exploring Causes and Treatments

5.

Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

2.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

3.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

5.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot